Combination of diltiazem and viral polymerase inhibitor

The present invention relates to a combination of diltiazem and at least one viral polymerase inhibitor compound selected from the group consisting of macavir, pimodivir, RO-7, and CC-42344. In particular, the invention relates to the therapeutic use of said combination for the prevention and/or treatment of viral infections, in particular of the respiratory tract and/or intestinal tract of the human or animal body. 本发明涉及地尔硫卓和至少一种病毒聚合酶抑制剂化合物的组合，所述病毒聚合酶抑制剂选自玛巴洛沙韦、吡莫地韦、RO-7和CC-42344。本发明特别涉及所述组合在预防和/或治疗病毒感染中的治疗用途，所述病毒感染特别是人体或动物体呼吸道和/或肠道的病毒感染。